Case study: pembrolizumab

old elderly man IV hospital
Researchers have highlighted a case where this newly listed medication led to drug‐induced autoimmune diabetes mellitus and colitis Pharmacist Nikhil Singh from the Royal Melbourne Hospital has shared a case study that highlights the potential for serious adverse events associated with pembrolizumab (Keytruda). In the Journal of Pharmacy Practice and Research, published by the SHPA,

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Capital gains
Next This week is Antibiotic Awareness Week